Diabetes_dentistryIV

advertisement
Diabetes mellitus
Dr. Kovács Tibor
II.sz. Belgyógyászati Klinika
2012
T. Kovács 2012
1
Worldwide prevalence of diabetes in 2000 and 2010
Population (million)
T. Kovács 2012
Prevalence of diabetes 8,6% in people
> 20 ys; 20,1% in people > 65ys
2
T. Kovács 2012
3
Diabetes mellitus
metabolic disorders,
leading symptom hyperglycaemia
T. Kovács 2012
4
T. Kovács 2012
5
T. Kovács 2012
6
Criteria for the diagnosis of
diabetes mellitus
1.
Symptoms of diabetes plus random blood glucose
conc. ≥ 11,1 mol/l (200 mg/dl)
2.
Fasting plasma glucose ≥7 mmol/l (126 mg/dl)
3.
Two-hour plasma glucose ≥ 11,1 mmol/l (200 mg/dl)
during an oral glucose tolerance test (with 75g
glucose)
Fasting is defined as no caloric intake for at least 8 h.
T. Kovács 2012
7
Symptoms of diabetes
first of all ...
T. Kovács 2012
8
Glucose transport in the kidney
Glucose reabsorption in proximal tubules by SodiumGlucose-cotransporter
high blood glucose level → glucosuria
Threshold for maximal glucose reabsorbing capacity
10 mmol/l (180 mg/dl).
T. Kovács 2012
9
...symptoms of diabetes








polyuria
polydipsia
polyphagia
weight loss
dry mouth
itching
recurrent infection
poor wound healing
T. Kovács 2012
10
Characteristic of type 1 diabetes
Rapid onset,
Typical symptoms
No sign of late complications at diagnosis
T. Kovács 2012
11
Model of pathogenesis and natural history of type 1 diabetes.
Islet cell autoantibodies (ICA)
Glutamic aciddecarboxylase (GADA)
Devendra D et al. BMJ 2004;328:750-754
T. Kovács 2012
©2004 by British Medical Journal Publishing Group
12
T. Kovács 2012
13
T. Kovács 2012
14
T. Kovács 2012
15
Natural history of insulin resistance and insulin
secretion in type 2 diabetes.
Holt R I G BJP 2004;184:s55-s63
T. Kovács 2012
16
Impaired insulin secretion in
type 2 diabetes
NGT
1st
2nd phase
early diabetes
2nd phase
IGT
1st
2nd phase
late diabetes
2nd phase
T. Kovács 2012
18
Comparison of type 1 and type 2 diabetes
Type 1 diabetes
Type 2 diabetes
Pathogenesis
Insulin lack
Insulin resistance
(relative insulin lack)
Age at onset
Children / young
BUT LADA
Adult (> 40 ys)
BUT MODY
Body weight
Normal
Obes
Onset
Rapid
Slow
Beta cell mass
<10%
at onset: normal
Later: decrease
Blood insulin level
Low/absent
At onset: high
Autoantibodies
Predispose for
ketosis
Yes
No
Yes
Not specific
Insulin therapy
Necessary
Not absolutely
T. Kovács 2012 necessary
19
T. Kovács 2012
20
Acute complications
• Diabetic coma
– Diabetic ketoacidosis (DKA)
– Hyperglycemic hyperosmolar state (HHS)
• Hypoglycemic state
• Hyperglycemic state
• Somogyi rebound or Dawn phenomen
T. Kovács 2012
21
T. Kovács 2012
22
T. Kovács 2012
23
T. Kovács 2012
24
Chronic complications
of diabetes
T. Kovács 2012
25
Diabetic foot
Pathogenic factors are:
autonomic neuropathy,
sensory neuropathy,
motor neuropathy,
peripherial artery disease.
microangiopathy,
infections.
T. Kovács 2012
26
Diabetic nephropathy
Stage
GFR
Urine protein
RR
1
norm.
neg
norm
2
high
neg
norm v. ↑
3
norm or high
microlbumin
↑
4
decreased
proteinuria
high
5
< 10 ml/min
T. Kovács 2012
high
27
T. Kovács 2012
28
Therapy
Life style modification
Drugs
T. Kovács 2012
29
Life style modification
• Regular physical activity,
• Weight loss,
• Regulate calory intake
– Weak physical activity 20 kcal/bwkg/day
– Medium physical activity 25 kcal/bwkg/day
– Haevy physical activity 30 kcal/bwkg/day.
T. Kovács 2012
30
Characteristic of diabetic diet
T. Kovács 2012
31
T. Kovács 2012
32
Glycemic index
T. Kovács 2012
33
T. Kovács 2012
34
Drug therapy
"Orally given antidiabetics”
Insulin
T. Kovács 2012
35
T. Kovács 2012
36
T. Kovács 2012
37
Discover of
GLP-1 action
T. Kovács 2012
38
T. Kovács 2012
39
T. Kovács 2012
40
T. Kovács 2012
41
T. Kovács 2012
42
T. Kovács 2012
43
T. Kovács 2012
44
Another ways:
Bed time regime
Insulin pump
T. Kovács 2012
45
T. Kovács 2012
46
Kezelés, gondozás célja
• Jó szénhidrát anyagcsere helyzet.
• Céltartományba kerülő vércukor
• Céltartományon belüli HbA1c érték
• Szövődmények elkerülése
T. Kovács 2012
47
Köszönöm a figyelmet!!
T. Kovács 2012
48
T. Kovács 2012
49
T. Kovács 2012
50
T. Kovács 2012
51
T. Kovács 2012
52
T. Kovács 2012
53
Krónikus szövődmények ...
• Diabetes neuropathia
– sensomotoros neuropathia (perifáriás)
• tapintás, fájdalom, vibráció, reflex
– autonóm neuropathia
• keringési rendszer
• gyomor-bé rendszer
• hugyúti rendszer
T. Kovács 2012
54
T. Kovács 2012
55
T. Kovács 2012
56
T. Kovács 2012
57
T. Kovács 2012
58
Megállapításának szempontjai
Ismételten magas éhomi vércukorszint:
≥ 7 mmol/l
(126 mg/dl)
→
6,1-6,9 mmol/l
→
(110-125 mg/dl)
Diabetes mellitus
károsodott glükóztolerancia
(IFG)
T. Kovács 2012
59
Diabeteszes retinopathia
• Nem proliferatív retinopathia
– microaneurizmák
– kevés intraretinalis vérzés
– kaliberingadozás
• Proliferatív retinopathia
– érújdonképződés
– papillaproliferatio
– preretinális vérzések
– retinaleválás
T. Kovács 2012
60
T. Kovács 2012
61
T. Kovács 2012
62
glp1rev.png
← Back to incretins_diabetes
Date:
2011/01/28 16:41
Filename:
glp1rev.png
Format:
PNG
Size:
515KB
T. Kovács 2012
63
T. Kovács 2012
64
Transport mechanisms in tubules
T. Kovács 2012
65
Download